- Home
- TLSI vs FRST Comparison
TLSI vs FRST Comparison
Compare TLSI & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- FRST
- Stock Information
- Founded
- TLSI 2010
- FRST 2004
- Country
- TLSI United States
- FRST United States
- Employees
- TLSI N/A
- FRST N/A
- Industry
- TLSI Medical Specialities
- FRST Major Banks
- Sector
- TLSI Health Care
- FRST Finance
- Exchange
- TLSI Nasdaq
- FRST Nasdaq
- Market Cap
- TLSI 204.0M
- FRST 220.5M
- IPO Year
- TLSI N/A
- FRST 2006
- Fundamental
- Price
- TLSI $5.54
- FRST $10.05
- Analyst Decision
- TLSI Strong Buy
- FRST Buy
- Analyst Count
- TLSI 5
- FRST 1
- Target Price
- TLSI $10.90
- FRST $420.00
- AVG Volume (30 Days)
- TLSI 39.7K
- FRST 73.3K
- Earning Date
- TLSI 08-13-2025
- FRST 07-24-2025
- Dividend Yield
- TLSI N/A
- FRST 3.97%
- EPS Growth
- TLSI N/A
- FRST N/A
- EPS
- TLSI N/A
- FRST 0.16
- Revenue
- TLSI $32,141,000.00
- FRST $125,133,000.00
- Revenue This Year
- TLSI $55.52
- FRST $21.33
- Revenue Next Year
- TLSI $54.76
- FRST $12.77
- P/E Ratio
- TLSI N/A
- FRST $62.78
- Revenue Growth
- TLSI 46.20
- FRST 22.34
- 52 Week Low
- TLSI $3.50
- FRST $7.59
- 52 Week High
- TLSI $6.08
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- TLSI 53.07
- FRST 62.67
- Support Level
- TLSI $5.18
- FRST $9.66
- Resistance Level
- TLSI $5.54
- FRST $9.95
- Average True Range (ATR)
- TLSI 0.32
- FRST 0.17
- MACD
- TLSI 0.01
- FRST 0.01
- Stochastic Oscillator
- TLSI 82.81
- FRST 93.83
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit.